[English] 日本語
Yorodumi
- PDB-6p7j: Crystal structure of Latency Associated Peptide unbound to TGF-beta1 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6p7j
TitleCrystal structure of Latency Associated Peptide unbound to TGF-beta1
ComponentsTransforming growth factor beta-1 proprotein
KeywordsCYTOKINE / pro-domain / latency / cancer / transforming
Function / homology
Function and homology information


frontal suture morphogenesis / Influenza Virus Induced Apoptosis / adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains / positive regulation of microglia differentiation / regulation of interleukin-23 production / positive regulation of primary miRNA processing / morphogenesis of a branching structure / negative regulation of skeletal muscle tissue development / regulation of striated muscle tissue development / response to laminar fluid shear stress ...frontal suture morphogenesis / Influenza Virus Induced Apoptosis / adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains / positive regulation of microglia differentiation / regulation of interleukin-23 production / positive regulation of primary miRNA processing / morphogenesis of a branching structure / negative regulation of skeletal muscle tissue development / regulation of striated muscle tissue development / response to laminar fluid shear stress / embryonic liver development / heart valve morphogenesis / macrophage derived foam cell differentiation / TGFBR2 MSI Frameshift Mutants in Cancer / regulation of protein import into nucleus / regulation of blood vessel remodeling / transforming growth factor beta complex / negative regulation of macrophage cytokine production / cellular response to acetaldehyde / connective tissue replacement involved in inflammatory response wound healing / negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target / negative regulation of hyaluronan biosynthetic process / extracellular matrix assembly / type III transforming growth factor beta receptor binding / myofibroblast differentiation / TGFBR2 Kinase Domain Mutants in Cancer / odontoblast differentiation / positive regulation of exit from mitosis / positive regulation of isotype switching to IgA isotypes / SMAD2/3 Phosphorylation Motif Mutants in Cancer / TGFBR1 KD Mutants in Cancer / positive regulation of mesenchymal stem cell proliferation / positive regulation of receptor signaling pathway via STAT / membrane protein intracellular domain proteolysis / positive regulation of extracellular matrix assembly / negative regulation of myoblast differentiation / TGFBR3 regulates TGF-beta signaling / positive regulation of vasculature development / hyaluronan catabolic process / ATP biosynthetic process / negative regulation of extracellular matrix disassembly / cell-cell junction organization / type II transforming growth factor beta receptor binding / positive regulation of branching involved in ureteric bud morphogenesis / receptor catabolic process / positive regulation of cardiac muscle cell differentiation / response to salt / TGFBR1 LBD Mutants in Cancer / regulatory T cell differentiation / positive regulation of chemotaxis / negative regulation of cell-cell adhesion mediated by cadherin / negative regulation of biomineral tissue development / type I transforming growth factor beta receptor binding / ureteric bud development / positive regulation of vascular permeability / positive regulation of mononuclear cell migration / oligodendrocyte development / odontogenesis of dentin-containing tooth / neural tube development / negative regulation of interleukin-17 production / face morphogenesis / phosphate-containing compound metabolic process / digestive tract development / response to cholesterol / sprouting angiogenesis / positive regulation of chemokine (C-X-C motif) ligand 2 production / response to vitamin D / positive regulation of fibroblast migration / lymph node development / aortic valve morphogenesis / RUNX3 regulates CDKN1A transcription / negative regulation of release of sequestered calcium ion into cytosol / negative regulation of fat cell differentiation / positive regulation of regulatory T cell differentiation / Molecules associated with elastic fibres / negative regulation of neuroblast proliferation / salivary gland morphogenesis / Syndecan interactions / cellular response to insulin-like growth factor stimulus / inner ear development / ventricular cardiac muscle tissue morphogenesis / negative regulation of phagocytosis / positive regulation of interleukin-17 production / response to immobilization stress / cellular response to dexamethasone stimulus / negative regulation of cell cycle / chondrocyte differentiation / positive regulation of collagen biosynthetic process / TGF-beta receptor signaling activates SMADs / positive regulation of protein metabolic process / hematopoietic progenitor cell differentiation / negative regulation of blood vessel endothelial cell migration / positive regulation of cell division / positive regulation of SMAD protein signal transduction / vasculogenesis / epithelial to mesenchymal transition / positive regulation of endothelial cell apoptotic process / positive regulation of vascular endothelial growth factor production / defense response to fungus / RUNX3 regulates p14-ARF
Similarity search - Function
Transforming growth factor beta-1 proprotein / Transforming growth factor-beta / TGF-beta, propeptide / TGF-beta propeptide / Transforming growth factor beta, conserved site / TGF-beta family signature. / Transforming growth factor-beta-related / Transforming growth factor-beta (TGF-beta) family / Transforming growth factor-beta, C-terminal / Transforming growth factor beta like domain ...Transforming growth factor beta-1 proprotein / Transforming growth factor-beta / TGF-beta, propeptide / TGF-beta propeptide / Transforming growth factor beta, conserved site / TGF-beta family signature. / Transforming growth factor-beta-related / Transforming growth factor-beta (TGF-beta) family / Transforming growth factor-beta, C-terminal / Transforming growth factor beta like domain / TGF-beta family profile. / Cystine-knot cytokine
Similarity search - Domain/homology
Transforming growth factor beta-1 proprotein
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 3.501 Å
AuthorsStachowski, T.R. / Snell, M.E. / Snell, E.H.
Funding support United States, 1items
OrganizationGrant numberCountry
National Science Foundation (NSF, United States)1231306 United States
CitationJournal: Iucrj / Year: 2020
Title: Structural insights into conformational switching in latency-associated peptide between transforming growth factor beta-1 bound and unbound states
Authors: Stachowski, T.R. / Snell, M.E. / Snell, E.H.
History
DepositionJun 5, 2019Deposition site: RCSB / Processing site: RCSB
Revision 1.0Mar 11, 2020Provider: repository / Type: Initial release
Revision 1.1Oct 11, 2023Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 1.2Nov 13, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Transforming growth factor beta-1 proprotein


Theoretical massNumber of molelcules
Total (without water)29,2741
Polymers29,2741
Non-polymers00
Water00
1
A: Transforming growth factor beta-1 proprotein

A: Transforming growth factor beta-1 proprotein


Theoretical massNumber of molelcules
Total (without water)58,5482
Polymers58,5482
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation3_556-x,y,-z+11
Buried area2230 Å2
ΔGint-1 kcal/mol
Surface area17590 Å2
MethodPISA
Unit cell
Length a, b, c (Å)51.060, 154.900, 62.250
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number21
Space group name H-MC222

-
Components

#1: Protein Transforming growth factor beta-1 proprotein


Mass: 29274.240 Da / Num. of mol.: 1 / Mutation: R249A
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: TGFB1, TGFB / Plasmid: pTT3 / Cell (production host): HEK293 / Production host: Homo sapiens (human) / References: UniProt: P01137
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.03 Å3/Da / Density % sol: 39.42 %
Crystal growTemperature: 293 K / Method: batch mode / pH: 4.6
Details: Reservoir composition: 20% PEG3350, 300 mM NaAc pH 4.6

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 17-ID / Wavelength: 1 Å
DetectorType: DECTRIS PILATUS 6M / Detector: PIXEL / Date: Nov 11, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 3.5→36.31 Å / Num. obs: 3332 / % possible obs: 99.6 % / Redundancy: 3.7 % / CC1/2: 0.899 / Rmerge(I) obs: 0.345 / Rpim(I) all: 0.209 / Rrim(I) all: 0.406 / Net I/σ(I): 3.1 / Num. measured all: 12411 / Scaling rejects: 46
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. measured allNum. unique obsCC1/2Rpim(I) allRrim(I) allNet I/σ(I) obs% possible all
3.5-3.833.51.6926687730.4671.1062.0341.199.5
8.57-36.313.90.0769862560.9880.0420.0876.798.3

-
Phasing

PhasingMethod: molecular replacement

-
Processing

Software
NameVersionClassification
PHENIX1.15rc3_3435refinement
MR-Rosettaphasing
Aimless0.7.3data scaling
PDB_EXTRACT3.25data extraction
MOSFLMdata reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 5VQP

5vqp


Resolution: 3.501→36.31 Å / SU ML: 0.49 / Cross valid method: THROUGHOUT / Phase error: 24.54
RfactorNum. reflection% reflection
Rfree0.3215 160 4.81 %
Rwork0.2881 --
obs0.2897 3329 99.49 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å
Displacement parametersBiso max: 224.46 Å2 / Biso mean: 111.1007 Å2 / Biso min: 40.77 Å2
Refinement stepCycle: final / Resolution: 3.501→36.31 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms1298 0 0 0 1298
Num. residues----159
LS refinement shellResolution: 3.501→3.625 Å / Rfactor Rfree error: 0
RfactorNum. reflection% reflection
Rfree0.3315 12 -
Rwork0.3296 324 -
obs--99 %

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more